Molecular Analysis Of Cyp21 Gene In Patients Presenting With Ambiguous Genitalia. by Fuziah, M Z et al.
I
I .
I MOLECULAR ANALYSIS of CYP21 GENE in
PATIENTS PRESENTING with AMBIGUOUS
GENITALIA
MZ FUZIAH 1, KM YULIA2, A. RUS ANIDA3, MR SIDEK2, SF
RAMLI2, MN ISA4
1 Department ofPaediatrics,2 Human Genome Centre, .School
ofMedicine, USM, 16150 Kubang ](erian, 3Department of
Paediatrics, Hospital [(ota Bharu, ](elantan, 4]nternational
Medical University, Putrajaya, Malaysia.
lema ..../\>1;ft.' , ., ~~",;
}i\r~'~:iL1~[~.;~;;· >: )\"I~f~;::~
Congenital adrenal hyp~rpJasia (CAH) is a group ofaut9$_OJ1)~~{J~'c"': ; ,; :}:' ~;;'i~~iJ?' f
disorders of adrenal steroidogenesis. The genes of the st~~=-i~:'. 1
enzymes and the mutations involved have been described. DetI~I~' f
the 21-hydroxylase (21-QH) enzyme is by far the most commpn, fQ, . ~.
CAH which arises as a result of deletions or deleterious. mutations 'iQ~ ....,~ W
active gene (CYP21) located on chromosome 6p. Many different mutatipns
of the CYP21 gene cause varying degrees of impairment of 21-0H activity
that results in a spectrum of disease _expression. There is no sharp limit
between the salt- wasting, the simple virilizing and the late onset forms.
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The objective of our study was to determine the 21-0H deficiency mutation
defects and correlate the genotype with their phenotypic _expression of
the disease.
We performed mutational analysis using PCR-ASOH (Polymerase Chain
Reaction - Allele Specific Oligonucleotide Hybridization) technique on six
patients who presented with ambiguous genitalia (AG) and or electrolyte
derangement as hyponatraemia and hyperkalaemia, suspected to have
CAH. The Val281 Leu and Pr030Leu mutations result in enzymes with 20-
60% of normal activity and both are associated with the non-classical form
of CAH. The Gln318stop mutation is categorized under the salt-wasting
type.
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Among the six patients, three had Val281 Leu mutation, two had Pr030Leu
mutation and one had Gln318stop mutation. The three patients with
Val281Leu mutation had presented with adrenal crises during infancy and
was classified as salt losers and treated with glucocorticoids and
mineralocorticoids. These 3 patients could well be the other 40% who are
categorized as salt-losers. The two patients with Pro30Leu mutations have
normal male external genitalia and presented with hyponatraemia and
hyperkalaemia. Only one patient required mineralocorticoid therapy that
was given for about 5 months duration. Subsequently he had normal
electrolytes level even without mineralocorticoid therapy. The Gln318stop
mutation was identified in one patient who presented with ambiguous
genitalia and adrenal crises.
Our study showed that the patients with genotype Val281 Leu, Pr030Leu
and Gln318stop mutations correlated with their phenotype. The mutation
analysis of CYP21 gene proved to be a good complementary investigation
and supportive to the diagnosis and management of our CAH patients.
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Ambiguous genitalia (AG) are one of the clinical presentations of
congenital adrenal hyperplasia (CAH). Congenital adrenal
hyperplasia is an autosomal recessive disease caused by logs
or severe decrease in the activity of 21-hydroxylase (21-0H).
This enzyme is one of the five enzymes necessary for cortisol
biosynthesis. Deficiency of the 21-0H is the most common form
of CAH accounting for 90-95% of all cases of CAH1,6.
Congenital adrenal hyperplasia presents a wide spectrum of
clinical manifestations and patients are divided into 3 groups:
salt wasting (SW), simple virilizing (SV) and non-classical (NC).
Salt wasting patients manifest as neonatal electrolyte
disturbances together with virilization of external genitalia at
birth in girls and early pseudoprecocious pUberty in boys, while
SV patients present the same manifestation as SW patients, but
without electrolyte disturbances. Non- classical patients present
with late onset symptoms of androgen excess, ranging from
progressive virilization and pseudoprecoclous puberty in
childhood to menstrual disturbances, infertility and hirsutism in
adult women2•
It was reported that more than 90% of cases of CAH are caused
by mutation of the CYP21 gene. This 21-0H (CYP21) gene is
located in the HLA class III gene region on chromosome 6p21.3
and consist of 10 exons3 • Majority of the mutations on the
CYP21 gene are Val281 Leu and Pr030Leu. These mutations were
reported to result in 20-60% of normal enzyme activity and both
are associated with the non-classical form of CAH4,5.
To detect the presence of point mutations in Pr030Leu,
lIe172Asn & Val281 Leu of CYP21 gene
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Figure 1: Presence of PCR product (873 bp) for CYP21 gene
exon 1-3 using 2.00/0 agarose gel electrophoresis. Lane M : 100
bp DNA ladder, lane N : negative control, lane 1, 2 : normal
samples, lane 3,4,5,6 : samples showing PCR amplification
products for CYP21 gene.
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Figure 2: Dot blotting was performed using 1 IJg genomic DNA.
The blot was hybridized with 100 pmollml of the digoxigenin
labeled antiphosphatase (DIG-AP) specific probe from samples
of patient 1-7. ASOH of PCR product from CAH patients was
performed with the probe corresponding to the site exon. The
status N: normal, P: patient.
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Figure 3: Pr030Leu hybridization DNA samples. Dot blotting
was performed using 1 IJg genomic DNA. The blot was
hybridized with 100 pmol Iml of the digoxigenin labeled
antiphosphatase (DIG-AP) specific probe Pr030Leu. ASOH of
PCR product from CAH patients was performed with the probe
(Pr030Leu) corresponding to the site exon 1. The status N:
normal, P: patient.
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Majority of the mutations in the CYP21 gene in our
patients are Val281 Leu and Pr030Leu. These mutations
were reported to result in 20-600/0 of normal enzyme
activity and both are associated with the non-classical
form of CAH4,7.
In our study, we found that 3/52 patients (5.7%) have
Val281 Leu while 2/52 patients (3.8%) have Pr030Leu
respectively. No mutations were observed in lIe172Asn.
Patients with Val281 Leu presented with adrenal crisis
during infancy and were classified as salt wasting. Two
patients with Pr030Leu mutations have normal male
external genitalia and presented with hyponatraemia
and hyperkalaemia. We did not identify any patient with
1172N mutation which is known to result in clearly
reduced enzymatic activity. About 1-2% of 1172N
mutation is usually associated with the SV form 8,9.
Our findings showed that patients with Pr030Leu
mutations were associated with non-classical form of
CAH whereas Val281 Leu mutations were associated
with salt wasting form of CAH.
This study suggested that phenotypes are not always
concordant with the genotype in patients with
Val281 Leu mutations dfagnosed with CAH.
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